Management of female genital warts with an analog of imiquimod 2% in cream: A randomized, double-blind, placebo-controlled study

Journal of Dermatology

Volumn 25, Issue 7, 1998, Pages 429-433

  Syed, Tanweer A ^a   Ahmadpour, Oliver Abbas ^b   Ahmad, Seyed Ali ^c   Ahmad, Seyed Hamzeh ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UMEÅ UNIVERSITY   (Sweden)

^c UNIVERSITY OF THE PUNJAB   (Pakistan)

Author keywords

Condylomata acuminata; Genital warts; Human papillomaviruses; Imiquimod; Pharmaceutical creams; Venereal diseases; Women

Indexed keywords

IMIQUIMOD; PLACEBO;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIAL; SEXUALLY TRANSMITTED DISEASE; TOPICAL DRUG ADMINISTRATION; VIRUS GENOME; VIRUS REPLICATION;

EID: 0031827261     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1998.tb02429.x     Document Type: Article

References (16)

1. Stanley MA: Virus-keratinocyte interactions in the infectious cycle, in Stern PL, Stanley MA (eds): Human Papillomavirus and Cervical Cancer-Biology and Immunology, Oxford University Press, Oxford, 1994, pp 116-131.
2. Obalek S, Jablonska S, Orth G: HPV associated intra-epithelial neoplasia of external genitalia, Clin Dermatol, 3: 104-113, 1985.
3. Baggish MS: Improved laser techniques for the elimination of genital and extragenital warts, Am J Obstet Gynecol, 153: 540-550, 1985.
4. Syed TA, Lundin S, Ahmad SA: Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of condylomata acuminata in women, Dermatology, 189: 142-145, 1994.
5. Syed TA, Lundin S, Cheema KM, et al: Human leukocyte interferon-α in cream for the treatment of genital warts in Asian women: A placebo-controlled, double-blind study, Clin Investig, 72: 870-873, 1994.
6. Syed TA, Khayyami M, Kriz D, et al: Management of genital warts in women with human leukocyte interferon-α vs. podophyllotoxin in cream: A placebo-controlled, double-blind, comparative study, J Mol Med, 73: 255-258, 1995.
7. Fujisawa H, Shivji GM, Kondo S, et al: Effect of a novel topical immunomodulator, S-28463, on keratinocyte cytokine gene expression and production, J Interferon Cytokine Res, 16: 555-559, 1996.
8. Baker GE, Tyring SK: Therapeutic approaches to papillomavirus infections, Dermatol Clin, 15: 331-340, 1997.
9. Witt PL, Ritch PS, Reding D, et al: Phase I trial of oral immunomodulator and interferon inducer in cancel patients, Cancer Res, 53: 5176-5180, 1993.
10. Lacey CJN, Fairley I: Medical therapy of genital human papilloma virus-related disease, Int J of STD & AIDS, 6: 399-407, 1995.
11. Weeks CE, Gibson SJ: Induction of interferon and other cytokines by imiquimod and its hydroxylated metabolite R-842 in human blood cells in vitro, J Interferon Res, 14: 81-85, 1994.
12. Tomai MA, Birmachu W, Case MT, et al: Imiquimod: In vivo and in vitro characteristics and Toxicology, in Aly R, Beutner KR, Maibach H (eds): Cutaneous Infection and Therapy, Marcel Dekker Inc, New York, 1997, pp 405-415.
13. Megyeri K, Au W-C, Rosztoczy I, et al: Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by Sendai virus utilize similar signal transduction pathways, Mol Cell Biol, 15: 2207-2218, 1995.
14. Beutner KR, Ferenczy A: Therapeutic approaches to genital warts (Review), Am J Med, 102: 28-37, 1997.
15. Ziegenmeyer J: The influence of the vehicle on the absorption and permeation of drugs, in Brandau R, Lippold BH (eds): Dermal ami Transdermal Absorption, Wissenschaftliche Verlagsgesellschaft, Munich, 1981, pp 73-86.
16. Tregear RT: Physical Functions of Skin, Academic Press, New York, 1966, pp 36-40.